CYTORI THERAPEUTICS, INC. 4
4 · CYTORI THERAPEUTICS, INC. · Filed Mar 10, 2017
Insider Transaction Report
Form 4
HARRIS JOHN DAVID
VP and GM Cell Therapy
Transactions
- Award
Incentive Stock Option (right to buy)
2017-03-08+42,000→ 42,000 totalExercise: $1.55Exp: 2027-03-08→ Common Stock (42,000 underlying)
Footnotes (1)
- [F1]Option shares shall vest and become exercisable over four (4) years in forty-eight consecutive monthly installments.